We disrupted mitochondrial dynamics balance in AML cell lines and patient-derived AML cells, and observed that depletion of pro-fusion (MFN1, MFN2, OPA1) effectors was a vulnerability of leukemic cells in vitro and in vivo. The gene discussed is MFN1; the disease is acute myeloid leukemia.